Recursion Pharmaceuticals
RXRX
$4.24
Share price
-11.85%
Change (1 day)
-52.52%
Change (1 year)
Categories
Recursion Pharmaceuticals (RXRX) - Total liabilities
Total liabilities on the balance sheet as of December 2024 : $0.41 Billion USD
According to Recursion Pharmaceuticals's latest financial reports the company's total liabilities are $0.41 Billion USD. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Recursion Pharmaceuticals - Total liabilities on balance sheet (from 2020 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | $0.41 B | 117.5% |
| 2023-12-31 | $0.19 B | -11.7% |
| 2022-12-31 | $0.21 B | 219.67% |
| 2021-12-31 | $67.4 M | -86.65% |
| 2020-12-31 | $0.50 B | 123.7% |
| 2019-12-31 | $0.22 B |